ANIXA BIOSCIENCES RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHThu, 30 Apr 2026 08:14:15 +0200https://images.finanzen.net/images/finanzen_net_neu.gifANIXA BIOSCIENCES RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netAnixa Biosciences legte Quartalsergebnis vorWed, 11 Mar 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-legte-quartalsergebnis-vor-15548033Anixa Biosciences äußerte sich am 09.03.2026 zu den Geschäftsergebnissen des am 31.01.2026 abgelaufenen Quartals.Der Verlust je Aktie wurde auf 0,08 USD beziffert. Im Vorjahresquartal hatte das Anixa Biosciences ...

]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-legte-quartalsergebnis-vor-15548033Anixa Biosciences: Bilanzzahlen zum vergangenen QuartalWed, 14 Jan 2026 06:35:06 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-bilanzzahlen-zum-vergangenen-quartal-15413861Anixa Biosciences hat am 12.01.2026 in der Finanzkonferenz die Quartalszahlen zum jüngsten Jahresviertel – Abschlussdatum 31.10.2025 – vorgestellt.Der Verlust je Anteilsschein wurde bei 0,09 USD vermeldet. ...

]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-bilanzzahlen-zum-vergangenen-quartal-15413861Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland ClinicMon, 15 Dec 2025 14:45:00 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-transfer-of-ind-for-breast-cancer-vaccine-from-cleveland-clinic-15358842

SAN JOSE, Calif., Dec. 15, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-transfer-of-ind-for-breast-cancer-vaccine-from-cleveland-clinic-15358842Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of ParticipantsFri, 12 Dec 2025 00:02:00 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-positive-phase-1-data-for-investigational-breast-cancer-vaccine-primary-endpoints-were-met-and-immune-response-observed-in-74-of-participants-15353861

Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose

Results Support Advancement of the Program into Phase 2 Development

]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-positive-phase-1-data-for-investigational-breast-cancer-vaccine-primary-endpoints-were-met-and-immune-response-observed-in-74-of-participants-15353861Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025Wed, 10 Dec 2025 15:00:00 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-to-participate-in-water-tower-research-fireside-chat-on-monday-december-15-2025-15349164

SAN JOSE, Calif., Dec. 10, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-to-participate-in-water-tower-research-fireside-chat-on-monday-december-15-2025-15349164Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Comme...Mon, 17 Nov 2025 14:15:00 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-world-health-organization-who-approval-of-international-non-proprietary-name-for-its-car-t-therapy-marking-a-key-milestone-toward-global-recognition-and-future-comme-15284239

SAN JOSE, Calif., Nov. 17, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-world-health-organization-who-approval-of-international-non-proprietary-name-for-its-car-t-therapy-marking-a-key-milestone-toward-global-recognition-and-future-comme-15284239Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025Mon, 10 Nov 2025 16:30:00 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-to-participate-in-water-tower-research-fireside-chat-on-tuesday-november-11-2025-15251438

SAN JOSE, Calif., Nov. 10, 2025 /PRNewswire/ -- ]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-to-participate-in-water-tower-research-fireside-chat-on-tuesday-november-11-2025-15251438Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland ClinicWed, 05 Nov 2025 14:55:00 +0100https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-execution-of-data-transfer-agreement-with-cleveland-clinic-15196572

Completion of key step in IND transfer for upcoming Phase 2 breast cancer vaccine clinical trial

SAN ...

]]>https://www.finanzen.net/nachricht/aktien/anixa-biosciences-announces-execution-of-data-transfer-agreement-with-cleveland-clinic-15196572